Skip Navigation Genome.gov - National Human Genome Research InstituteGenome.gov - National Human Genome Research InstituteGenome.gov - National Human Genome Research InstituteNational Institutes of Health
   
       Home | About NHGRI | Newsroom | Staff
Research Grants Health Policy & Ethics Educational Resources Careers & Training
Division of Intramural Research

Overview
Organizational Chart
Research Branches
Cancer Genetics Branch
Genetic Disease Research Branch
Genetics & Molecular Biology Branch
Genome Technology Branch
Inherited Disease Research Branch
Medical Genetics Branch
Social and Behavioral Research Branch
Research Investigators
Profiles, publications, links
Clinical Research
Clinical trials, patient recruitment, IRB, FAQ, Overview
NHGRI Affiliated Centers
CIDR, NCGC, NISC
Online Research Resources Developed at NHGRI
Databases, software, tools, more.
Division of Intramural Research Calendar
Workshops, conferences, seminar series, courses, more.
Books and Publications



In Other Sections:

Office of Intramural Management

Intramural Training Office

Office of Laboratory Animal Medicine

Technology Transfer Office

Training Programs




Home>Research>Intramural Research>Research Branches at NHGRI>Genome Technology Branch >Mullikin Lab

Jim Mullikin

Jim Mullikin, Ph.D.

Associate Investigator
Genome Technology Branch

Head
Comparative Genomics Unit

B.S. Purdue University, 1982
M.S. Purdue University, 1984
Ph.D. Delft University of Technology, Holland, 1993
phone (301) 496-2416
fax (301) 480-0634
e-mail mullikin@mail.nih.gov
5625 Fishers Ln
Room 5N-01Q, MSC 9400
Rockville, MD 20892-9400
Selected Publications



Dr. Mullikin develops and utilizes computer programs to analyze large data sets generated through systematic DNA sequencing projects. A highly skilled computational geneticist, he collaborates extensively with other genomic researchers, analyzing data others collect or that are available in public databases.

His main work involves creating algorithms for performing complex computations. He designed one such program, called Sequence Search and Alignment by Hashing Algorithm (SSAHA), to dramatically accelerate the speed at which gigabases of DNA sequence are searched for single nucleotide poymorphisms (SNPs). It was developed several years ago, and Dr. Mullikin is still refining SSAHA in response to the continually changing needs of genomic scientists. SSAHA remains the key tool that he and others use to detect genetic variation. He also developed a program called Phusion—pronounced "FUSION"— for assembling a genomic sequence from a whole-genome shotgun data. The genomic sequences of both mouse and the nematode (Caenorhabditis elegans) were assembled using Phusion.

Dr. Mullikin’s group also provides computational support to major NHGRI efforts, such as the International Haplotype Map (HapMap) Project, which is primarily focused on determining genes and genetic variations that affect health and disease susceptibility. In the initial phase of the project, investigators aim to produce a working HapMap consisting of about 600,000 polymorphic sites roughly five kilobases apart from one another. Some particularly complex regions will need even higher resolution. When completed, the HapMap Project will give researchers a powerful tool for isolating and identifying disease genes through association studies.

In addition, Dr. Mullikin is developing algorithms for NHGRI’s comparative sequencing efforts, which involve the sequencing of many additional vertebrate genomes to help annotate the human sequence. Because only one percent to two percent of the human genome codes for protein, comparing the human genome with that of other vertebrates is key to highlighting other regions that are functionally important. In humans and mice, for example, as much as three percent of the noncoding sequence seems to have been conserved. Dr. Mullikin and other scientists are working to determine what these conserved, noncoding sequences are doing; some probably are involved in gene regulation, while others may have structural roles.

In one project, he is developing signal processing algorithms for sorting out the confusion that can result when polymerase chain reaction technology is used to amplify a segment of the genome for subsequent SNP discovery. During such a process, two copies of every chromosomal region (except for those on the X and Y chromosomes in males) can get sequenced. This can be confusing in heterozygous cases, where the regions contain different SNPs. Simply allowing for the possibility of a heterozygous state is not the answer; it merely increases the error rate. Dr. Mullikin is trying to devise software for unraveling the signals so the correct information can be captured. To take the algorithm a step farther, he is working on methods for reliably detecting insertion-deletion polymorphisms—situations where an entire sequence is inserted or deleted, which creates a much more complicated signal than does an individual base change. His work should make it possible to extract that information from the mixed signals.

Top of page

Last Updated: August 1, 2008




Print Version


Other Genome Technology Branch Investigators

Christopher P. Austin, M.D.

Andy Baxevanis, Ph.D.

Robert W. Blakesley, Ph.D.

Gerard Bouffard, Ph.D.

Lawrence C. Brody, Ph.D.

Shawn Burgess, Ph.D.

Settara C. Chandrasekharappa, Ph.D.

Laura L. Elnitski, Ph.D.

Eric D. Green, M.D., Ph.D.

James Inglese, Ph.D.

Elliott Margulies, Ph.D.

Elizabeth G. Nabel, M.D.

Tyra Wolfsberg, Ph.D.



PrivacyCopyrightContactAccessibilitySite MapStaff DirectoryFOIAHome Department of Health and Human Services  National Institutes of Health  USA.gov